Christoph Ellebrecht is a Dermatology physician affiliated with University of Pennsylvania. OpenAlex indexes 68 publications with 2,906 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
Philadelphia, PA 19104
Telephone
215-350-3997Provider last certified this registry record 15 Jun 2021.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Krystal Biotech IncProgram year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
- Terumo BCT, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
41.7%Interleukin-4 Receptor alpha Antagonist33.3%Dupixent Pen83%Dupixent Syringe18%Part D<11 patientsCorticosteroid8.4%Triamcinolone Acetonide100%Part D≥25 patientsMetabolism & gastrointestinal
22.2%Corticosteroid22.2%Prednisone100%Part D≥27 patientsSensory organs
17.2%Corticosteroid17.2%Clobetasol Propionate49%Dexamethasone37%Hydrocortisone14%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- Elucidating the role of protein translation efficiency in T cell adaptation to human skin
University of Pennsylvania
FY2026$2,063,666R01AR086989 - Engineering enhanced chimeric autoantibody receptor T cell therapy for Pemphigus Vulgaris
University of Pennsylvania
FY2026$563,203R01AR088051 - Deciphering novel cell death mechanisms and metabolic reprogramming in response to microenvironmental stress.
University of Pennsylvania
FY2026$446,875R35GM159930
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Current advancements in cellular immunotherapy for autoimmune disease
Seminars in Immunopathology
2025 - Divergent ontogeny of Tissue Resident Memory and Tissue Resident Exhausted CD8 <sup>+</sup> T cells underlies distinct functional potential
bioRxiv (Cold Spring Harbor Laboratory)
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Ravi Amaravadi, MD
University of Pennsylvania
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”